Abstract
A recent study pitted today's most popular AI chatbots -- ChatGPT-4, Google's Gemini, and Claude -- against each other in a simulated clinical setting. The results were surprising, and showed that while AI has come a long way, it still has a lot to learn.
Key Data
-
Publication Date13 June 2025
-
Primary AuthorMike Varshavski
-
SourceMedPage Today
-
LanguageEnglish
Click below to visit original source: